T1235 Randomised, Double-Blinded, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohns Disease

MLA

Peter A. Bampton, et al. “T1235 Randomised, Double-Blinded, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohns Disease.” Gastroenterology, vol. 138, May 2010, p. S-517. EBSCOhost, https://doi.org/10.1016/s0016-5085(10)62390-6.

APA

Peter A. Bampton, John Ombiga, Ian C. Lawrance, Robert P. Willert, & Kiran K. Peddi. (2010). T1235 Randomised, Double-Blinded, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohns Disease. Gastroenterology, 138, S-517. https://doi.org/10.1016/s0016-5085(10)62390-6

Chicago

Peter A. Bampton, John Ombiga, Ian C. Lawrance, Robert P. Willert, and Kiran K. Peddi. 2010. “T1235 Randomised, Double-Blinded, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohns Disease.” Gastroenterology 138 (May): S-517. doi:10.1016/s0016-5085(10)62390-6.